Risks
3 risks
Risk Intelligence
Sustained high competitive intensity in trade
View Risks →Colgate Palmolive (India) Limited — Q4 FY25
Colgate-Palmolive India reported Q4 FY25 revenue of INR 1,452 crore, a -1.9% decline YoY, with flat volumes and negative pricing due to elevated trade promotions.
neutral
medium
Financial stats pending filing verification
2-Minute Summary
✦ AI-Generated from Full Transcript
Colgate-Palmolive India reported Q4 FY25 revenue of INR 1,452 crore, a -1.9% decline YoY, with flat volumes and negative pricing due to elevated trade promotions. Full-year revenue reached INR 5,999 crore, up 6.5% YoY, driven by mid-to-high single-digit volume growth. EBITDA margin for Q4 was 34.3%, supported by cost efficiencies rather than pricing. The company highlighted a softening in urban demand, particularly in the bottom 70% of urban India, while rural remained resilient. Premiumization continues to outperform, with Colgate Total growing at over 4x market growth. Management expects urban demand to recover in the second half of FY26. Key risks include sustained high competitive intensity in trade and potential margin pressure from reinvestments in product quality and brand building.
कोलगेट-पामोलिव इंडिया ने चौथी तिमाही में 1,452 करोड़ रुपये की कमाई की, जो पिछले साल से 1.9% कम है। इसकी वजह बिक्री पर ज्यादा छूट देना है। पूरे साल की कमाई 5,999 करोड़ रुपये रही, जो 6.5% बढ़ी, क्योंकि बिक्री की मात्रा बढ़ी। कंपनी का मुनाफा 34.3% रहा, जो कीमतें बढ़ाने से नहीं, बल्कि खर्च कम करने से आया। शहरों में मांग कमजोर हुई है, खासकर 70% गरीब शहरी लोगों में, जबकि गांवों में मांग मजबूत है। कोलगेट टोटल जैसे महंगे उत्पाद बाजार से चार गुना तेजी से बिक रहे हैं। कंपनी को उम्मीद है कि अगले साल की दूसरी छमाही में शहरी मांग सुधरेगी। मुकाबला बढ़ने और गुणवत्ता पर ज्यादा खर्च से मुनाफा कम हो सकता है।
Risks3 trackedTranscriptfull text
Research workspace
Focused Modules
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Top of Mind Awareness
69%
Stable YoY
Brand awareness remained at 69% for 2024 and Q1 2025, indicating strong brand recall.
Oral Health Score
2.5/5
N/A
India's oral health score is 2.5 out of 5, with 24% of population scoring 1/5.
Colgate Total Growth vs Market
4x market growth
N/A
Colgate Total grew at over 4 times the category growth rate, driven by premiumization.
Advertising Spend
INR 822 crore
+13.8% YoY
Full-year advertising spend increased to INR 822 crore, making Colgate among the largest advertised FMCG brands.
What Changed vs Last Quarter
NEW
Urban demand recovery expected in H2 FY26
Management expects the softness in urban demand, particularly in the bottom 70%, to persist in the near term and recover towards the back half of FY26.
NEW
EBITDA margin to remain in low 30% range
Management reiterated that EBITDA margins will operate in the low 30% range, with potential quarterly fluctuations, supported by cost efficiencies.
NEW
Premiumization to grow at 4x portfolio rate
Premium products are expected to continue growing at 4x the rate of the rest of the portfolio, driven by innovation and premium launches.
DROPPED
Premium portfolio to grow 2.5-3x faster than core
Management targets premium brands (Total, Visible White) to grow at 2.5-3 times the rate of the core portfolio, currently exceeding that target.
DROPPED
Rural growth outpacing urban by ~200 bps
Rural markets are growing faster than urban by about 200 basis points, expected to be sustainable with improving macros.
DROPPED
Margins to remain around current levels
Management indicated that the large margin expansion seen in FY24 is a one-off; margins are expected to stay in the current ballpark rather than expand further.
DROPPED
Personal care growth to accelerate vs oral care
Personal care (Palmolive) is growing faster than oral care and the growth gap is expected to widen in coming quarters.
NEW RISK
Sustained high competitive intensity in trade
Competitors have increased trade spending, pressuring Colgate's pricing and volumes. Management noted this as an aberration but expects it to persist near-term.
NEW RISK
Urban demand weakness in bottom 70%
Softness in urban mass-market demand has led to volume titration by consumers, impacting overall growth. Recovery is uncertain and may take longer than expected.
NEW RISK
Margin pressure from reinvestment in product quality
Upgrading product formulations and increasing brand investment may pressure margins if cost savings are insufficient to offset these spends.
RISK GONE
Margin expansion may moderate
Management explicitly stated that the 400 bps margin expansion is a one-off and margins will likely stabilize, not continue expanding at the same pace.
RISK GONE
Volume growth not disclosed
Despite repeated analyst requests, management declined to break down revenue into volume, price, and mix, creating uncertainty about underlying volume trends.
RISK GONE
Personal care disruption risk
An analyst raised concerns about disruption in the body wash category from value players; management downplayed it, citing low penetration, but the segment remains competitive.
RISK GONE
Premiumization adoption slower than expected
Only 12% of toothpaste sales are above INR 140 index; premiumization depends on consumer willingness to upgrade, which may be slower in a price-sensitive market.
Fast read
Guidance and risk preview
Management expects the softness in urban demand, particularly in the bottom 70%, to persist in the near term and recover towards the back half of F...
Competitors have increased trade spending, pressuring Colgate's pricing and volumes.
View Risks →